Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Drug Abuse
- Drug Abuse in Pregnancy
- Drug Addiction
- Neonatal Abstinence Syndrome
- Neonatal Opiate Withdrawal Syndrome
- Opioid Related Disorders
- Pregnancy Related
- Substance Abuse
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03911739
- Collaborators
- National Institute on Drug Abuse (NIDA)
- The Emmes Company, LLC
- Investigators
- Principal Investigator: Theresa Winhusen, PhD University of Cincinnati
Get Well Soon